Embecta (EMBC) Cash & Equivalents (2022 - 2026)
Embecta (EMBC) reported Cash & Equivalents of $184.9 million for Q1 2026, down 11.66% on a YoY basis from $209.3 million in Q1 2025, and down 8.15% sequentially from $201.3 million in Q4 2025.
Embecta (EMBC) Cash & Equivalents (2022 - 2026) Analysis & Trends
Embecta (EMBC) has 5 years of Cash & Equivalents data on file, last reported at $184.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 11.66% year-over-year to $184.9 million; the trailing twelve-month figure through Mar 2026 stood at $184.9 million (down 11.66% YoY), and the FY2025 full-year result was $225.5 million, down 15.7% from the prior year.
- Cash & Equivalents fell to $184.9 million in Q1 2026, from $201.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $385.2 million in Q4 2022 to a low of $184.9 million in Q1 2026.
- A 5-year average of $274.4 million and a median of $275.1 million in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents surged 31.06% in 2023 and plunged 30.19% in 2025, its largest moves.
- Tracing EMBC's Cash & Equivalents over 5 years: stood at $385.2 million in 2022, then decreased by 22.46% to $298.7 million in 2023, then dropped by 29.7% to $210.0 million in 2024, then fell by 4.14% to $201.3 million in 2025, then dropped by 8.15% to $184.9 million in 2026.
- Business Quant data shows EMBC's Cash & Equivalents at $184.9 million in Q1 2026, $201.3 million in Q4 2025, and $225.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | 184.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.90 Mn |
| Dec 31, 2025 | 201.30 Mn |
| Sep 30, 2025 | 225.50 Mn |
| Jun 30, 2025 | 230.60 Mn |
| Mar 31, 2025 | 209.30 Mn |
| Dec 31, 2024 | 210.00 Mn |
| Sep 30, 2024 | 267.50 Mn |
| Jun 30, 2024 | 275.10 Mn |
| Mar 31, 2024 | 299.80 Mn |
| Dec 31, 2023 | 298.70 Mn |
| Sep 30, 2023 | 326.30 Mn |
| Jun 30, 2023 | 317.40 Mn |
| Mar 31, 2023 | 346.40 Mn |
| Dec 31, 2022 | 385.20 Mn |
| Sep 30, 2022 | 330.90 Mn |
| Jun 30, 2022 | 292.30 Mn |
| Mar 31, 2022 | 264.30 Mn |